The 2019 Protein Engineering Summit (PEGS) in Boston is the industry’s preeminent event that inspires innovative biotherapeutic protein drug development.
Plan to meet the IPA team at our booth (#622) to find out how to accelerate therapeutic antibody discovery utilizing advanced, innovative technologies yielding greater candidate diversity than traditional methods. Or, schedule a meeting to discuss a custom antibody discovery plan for your next project.
Attending from IPA:
At hubXchange’s European Antibody Therapeutics event, held in Munich on March 21st, Dr. Debby Kruijsen will lead a round-table discussion entitled “Implementing discovery strategies to value the therapeutic potential of lead antibody candidates” while Nienke Smits will present a poster entitled “DeepDisplay™: a powerful and unique human lead antibody discovery platform utilizing OmniMouse®”.
While attending this event, the ImmunoPrecise team will also be participating in one-on-one meetings with current and potential clients.
Hilton Munich Park, Munich, Germany
Am Tucherpark 7, 80538
Dates: March 21, 2019
Contact us today to learn more about how we may help with your antibody discovery and protein engineering needs to accelerate your therapeutic pipeline.
ImmunoPrecise will be exhibiting at the Americas Antibody Congress 2019 at Festival of Biologics, a multi-streamed, co-located conference & technology exhibition March 4 – 5, 2019 at the Grand Hyatt, in San Diego, California.
Connect with us at Booth #11
Attending from ImmunoPrecise will be Dr. Jennifer Bath and Kari Graber. Stop by booth #11 to learn more about how we may help with your antibody discovery and protein engineering needs to accelerate your therapeutic pipeline.
Grand Hyatt, San Diego, CA, USA
March 4 – 5, 2019
ImmunoPrecise will be attending PepTalk 2019, the Protein Science Week, from January 14-18th, 2019. PepTalk is the largest annual gathering of protein science researchers in the world. The conference focuses on intensive learning to discover new opportunities, apply alternative solutions and develop promising partnerships through keynote speakers, seminars and short courses.
Meet Us at Booth 700
Attending from ImmunoPrecise will be Dr. Deanna Dryhurst and Fiona Zhang-Ruane. Schedule a meeting and stop by booth #700 to learn more about how we may help with your antibody discovery and protein engineering needs to accelerate your therapeutic pipeline.
San Diego Hilton Bayfront, San Diego, CA
January 14-18, 2019
ImmunoPrecise will be attending Antibody Engineering & Therapeutics 2018, the annual meeting of The Antibody Society, where you can find the latest science, technologies and partners in antibody engineering, immunobiology, and next generation biomarkers.
Meet Us at Booth 107
Meet with our global team at Booth #107 to find out more about our comprehensive collection of antibody discovery platforms and how we can accelerate next generation antibodies to commercial success. This event features plenty of opportunities for networking and collaborating with leading pharma, biotech, and academia from North America, Asia, and Europe.
Schedule a Meeting with us to learn about how we can further your therapeutic antibody discovery.
Manchester Grand Hyatt San Diego
San Diego, CA
December 9-13, 2018
ImmunoPrecise, ModiQuest Research, and U-Protein Express will be attending the 10th annual PEGS Summit Europe. PEGS (Protein & Antibody Engineering Summit) is the largest European event for all aspects of protein and antibody engineering, offering keynote speakers, seminars, dedicated networking, and short courses.
Meet Us at Booth 615
Meet with our team at booth #615 to learn more about our full service cycle of therapeutic antibody discovery. Dr. Jos Raats, Dr. Roland Romijn, and Nienke Smits and will be attending from ModiQuest Research and U-Protein Express. Contact us to set up a meeting.
Interested in meeting attendees with similar interests and goals? Check out PEGS Europe’s new 1-on-1 networking system.
Location: Lisbon Congress Center
Date: November 12th-16th, 2018
ImmunoPrecise at European Antibody Congress 2018
ImmunoPrecise is excited to announce that we will be a part of the European Antibody Congress within the Festival of Biologics in Basel, Switzerland from October 29th to 31st.
The European Antibody Congress is a multi-streamed conference and technology exhibition that brings together over 1000 attendees, including representatives from big pharma, biotechs, academia and technology innovators. Offering opportunities for networking with industry peers, conference segments featuring enlightening talks from industry leaders, and an exhibition showcasing the latest technical innovations in the field, the event is the perfect place to feel connected and inspired.
ImmunoPrecise’s CSO, Dr. Deanna Dryhurst will be in attendance, along with ModiQuest’s Head of Contract Research, Dr. Debby Kruijsen who will also be a feature speaker in the on-floor seminar’s Drug Discovery Technology panel discussion. The panel will address modern therapeutics antibody drug discovery technologies and how our platforms can face the challenges of drug discovery. The panel will take place on Day 1, October 29th, at 12:45-13:25.
Congress Centre Basel
Messepl. 21, 4058 Basel, Switzerland
October 29th to 31st, 2018.
View the conference agenda here.
ImmunoPrecise at US West Coast Antibody Engineering Xchange 2018
ImmunoPrecise is excited to announce that we will be attending hubXchange’s US West Coast Antibody Engineering Xchange in San Diego on September 26th, 2018.
HubXchange specializes in delivering high-level content, intelligence and connections to the global Life Sciences community by hosting outstanding business Xchanges. These meetings are a series of highly-interactive roundtable discussions bringing together executives and senior academics over the course of one day. This ‘sharing-learning‘ platform is a powerful tool helping to address and find solutions to real-world industry challenges. HubXchange’s US West Coast Antibody Engineering Xchange 2018 will bring together executives from the pharma and biotech sectors, as well academia.
ImmunoPrecise will be presenting the keynote industry talk and facilitating two roundtable discussions focused on antibody discovery- providing insight and offering solutions on how we can face challenges in the antibody engineering industry.
Roundtable Discussion Topics
Maximizing Target-Specific Antibody Sequence Diversity in Discovery Campaigns
Facilitated by Dr. Barry Duplantis – Client Relations & Project Manager
Improving Efficiency in Identifying Lead Candidates
Facilitated by Dr. Andra Li – Director of Molecular Laboratory Services
Handlery Hotel, 950 Hotel Circle Drive,
September 26th, 2018.
ImmunoPrecise is excited to be exhibiting at this year’s Discovery on Target conference from September 25th to 28th in Boston, MA. Visit booth #213 at the Sheraton Boston, and discover how ImmunoPrecise can further your therapeutic antibody development. With over 1,300 drug discovery professionals in attendance, representing over 20 different countries, DOT 2018 is the perfect opportunity to learn, connect, and share information in this rapidly expanding and constantly developing field.
Click here to schedule a meeting with one of our delegates from ImmunoPrecise or Modiquest Research!
Meet with one of our representatives to discuss our featured services
- B-cell Select
- Human Monoclonals
- Advanced Hybridoma Development
- Phage Display
- Rabbit Monoclonals
- Rapid Prime Immunization
- Genetic Immunization
- Antibody Characterization and Optimization
- Antibody Engineering
- Protein & Antibody Expression
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery. We deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.
ImmunoPrecise operates from state-of-the-art laboratory facilities located at the Vancouver Island Technology Park in Victoria, British Columbia, in collaboration with its wholly-owned subsidiary operations at U-Protein Express B.V., in the Life Science Incubator, Utrecht, and ModiQuest Research, Oss, both in the Netherlands.
Set up a meeting to learn more!
About Discovery on Target
The 16th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets,” will once again gather over 1,300 drug discovery professionals in Boston, MA, this September. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.
ImmunoPrecise & ModiQuest Reseach B.V. will be exhibiting at the upcoming Antibody Engineering & Therapeutics Europe in Amsterdam! Come visit us at Booth #10
- B cell Selection Technologies
- Advanced Hybridoma Development
- Antibody Characterization & Optimization
- Phage Display
- Preferred OmniAb® Service Provider
- Antibody Humanization
- Custom Naïve & Immune Human Libraries
- Protein Expression
- Proprietary Immunization Strategies
ImmunoPrecise Antibodies Ltd. is a full-service, antibody discovery CRO focused on the next generation of antibody discovery. We aim to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with highest probability of succeeding to clinical trials.
IPA is a single source provider of services for the complete antibody discovery value chain. We offer the most comprehensive collection of antibody discovery platforms in the industry, combined with state of the art lead candidate optimization and characterization. This allows us to assist clients from the moment they identify a therapeutic target to the preparation of applying for investigation review of the clinical product.
AET Europe Information:
Brought to you by the same organizers of Antibody Engineering & Therapeutics US, in conjunction with The Antibody Society; AET Europe brings together the latest science, technologies, and partners needed to accelerate next generation antibodies to commercial success.
AET Europe will be held at the Hilton Amsterdam:
Apollolaan 138, 1077 BG